Skip to main content

Table 4 Comparison of BMD measures (g/cm2) resulting in discontinuation to the previous measurement (n = 23 for spine and n = 19 for femur)

From: Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

BMD Score

Measure after January 2006 resulting in discontinuation (g/cm2)

Prior measure (g/cm2)

Difference (p value of the test of difference)

Spine

0.756

0.813

-0.0534 (<0.001)

Femur

0.664

0.699

-0.0338 (0.01)

  1. BMD: bone mineral density
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us